Histone deacetylatse (HDAC) inhibitors

Histone deacetlyase inhibitors are a new type of myeloma treatment currently in clinical trial. Dr Charlotte Pawlyn explains how these inhibitors work and how they are likely to be given to patients.

Related Videos